Loading the security overview…
Where the tokens are
| Settlement | Shares short | Average daily volume | Days to cover |
|---|---|---|---|
| Sep 15, 2026 | 15.15M | 1.31M | 11.59 |
| Aug 31, 2026 | 14.88M | 1.71M | 8.69 |
| Aug 14, 2026 | 14.64M | 2.92M | 5.01 |
| Jul 31, 2026 | 14.02M | 1.68M | 8.35 |
| Jul 15, 2026 | 13.3M | 1.83M | 7.27 |
| Jun 30, 2026 | 13.23M | 2.11M | 6.27 |
| Jun 15, 2026 | 12.95M | 1.65M | 7.84 |
| May 29, 2026 | 13.64M | 1.68M | 8.12 |
| May 15, 2026 | 13.39M | 1.99M | 6.72 |
| Apr 30, 2026 | 14.38M | 1.41M | 10.22 |
| Apr 15, 2026 | 14.26M | 1.35M | 10.57 |
| Mar 31, 2026 | 14.05M | 1.49M | 9.41 |
The share of each day’s reported trading that was a short sale. This is not short interest: most of it is market makers selling short to fill buy orders and buying back within the day, so a ratio of 30–50% is ordinary for a heavily traded stock and says little about how many shares are held short overnight.
Figures describe Halozyme Therapeutics shares, not any token. As of Sep 15, 2026, from exchange short-interest reports and FINRA short-sale volume, via Massive. Short sellers borrow and sell the shares themselves; token holders are not lending theirs.